Related Experiment Videos
Enhancement of left ventricular function by glucose-insulin-potassium in acute myocardial infarction
The American Journal of Cardiology
|March 15, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
New insights in the dihydroxybenzenes-driven Fenton reaction: electrochemical study of interaction between dihydroxybenzenes and Fe(III).
Water science and technology : a journal of the International Association on Water Pollution Research·2011
Effectiveness of different kidney exchange mechanisms to improve living donor transplantation in Chile.
Transplantation proceedings·2011
Long-Term Outcomes of Intravascular Ultrasound-Guided Versus Angiography-Guided Percutaneous Coronary Intervention for Non-Complex Atherosclerotic Lesions.
The American journal of cardiology·2026
A Novel 2-Hz Coronary Intravascular Lithotripsy Catheter for Calcified Coronary Artery Disease: One-Year Outcomes of the DISRUPT CAD Duo Trial.
The American journal of cardiology·2026
Side-Branch Intervention After Crossover Stenting for Medina 0.0.1 and 0.1.0 Left Main Bifurcation Lesions (The Multicenter SIBIS Study).
The American journal of cardiology·2026
Procedural Characteristics and Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With and Without Prior CABG.
The American journal of cardiology·2026
Endothelial Plasticity as a Continuum in the Tumor Microenvironment.
Vascular biology (Bristol, England)·2026
Extracellular matrix-inspired single-network gels with tunable tissue-like toughness and viscoelasticity for high-fidelity organ phantoms.
Journal of materials chemistry. B·2026
SNX3 exacerbates hepatic fibrosis by amplifying TGF-β1/Smad signaling pathway in hepatocyte-HSC fibrotic loop.
Acta pharmaceutica Sinica. B·2026
Compensatory Mitophagy via NEDD4/HIF-1α/BNIP3 Pathway Restrains EndMT and Renal Allograft Interstitial Fibrosis Induced by TNFα.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
18 Month patency of acellular bioengineered regenerative conduit as coronary artery bypass.
Nature communications·2026